Company:  NANOSPHERE INC (NSPH)
Form Type:  8-K
Filing Date:  5/8/2013 
CIK:  0001105184 
Address:  4088 COMMERCIAL AVE 
City, State, Zip:  NORTHBROOK, Illinois 60062 
Telephone:  847-400-9000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.82  
Change: 
-0.03 (-1.62%)  
Trade Time: 
Apr 24  
Market Cap: 
$139.99M
Description of Business
References herein to �we,� �us,� �our� or �the Company� refer to Nanosphere, Inc. unless the context specifically requires otherwise. Overview We are dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics. Our platform, the Verigene� System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases. The Verigene System includes a bench-top molecular diagnostics workstation that is an advanced platform for genomic and protein testing. The Verigene System is differentiated by its ease of use, superior analytical performance and ability to detect many targets on a single test, referred to as �multiplexing.� It provides faster results, lower cost and less labor for hospital-based laboratories.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02. Results of Operations and Financial Condition
    SECTION 7 REGULATION FD
      Item 7.01 Regulation FD Disclosure
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 99.1
    INCOME STATEMENT
    BALANCE SHEET
BROKERAGE PARTNERS